Monstarlab（5255）株式概要Monstarlab Inc.はその子会社とともに、アジア太平洋、欧州、中東、アフリカ、米州で情報技術事業に従事している。 詳細5255 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性3/6配当金0/6リスク分析JP市場と比較して、過去 3 か月間の株価の変動が非常に大きい過去5年間で収益は年間26.5%減少しました。 過去1年間で株主の希薄化は大幅に進んだ 意味のある時価総額がありません ( ¥7B )すべてのリスクチェックを見る5255 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueJP¥Current PriceJP¥104.00339.9% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-10b14b2016201920222025202620282031Revenue JP¥6.2bEarnings JP¥472.3mAdvancedSet Fair ValueView all narrativesFeatured narrative•Software opportunityZenaTechabout 2 months ago author updated this narrativeJOFair Value from Jolt_CommunicationsUS$6.8569.3% 割安 内在価値ディスカウントZenaTech: A big bet on the rise of AI drones and drones-as-a-serviceKey Takeaways ZenaTech is focusing its efforts into building AI drones, combining Drone as a Service, SaaS, and AI as its key revenue drivers. Previously building software for agriculture, ZenaTech has shifted rapidly toward drone services, now driving ~70% of revenue after recent acquisitions.Read full narrative3.2kusers have viewed this narrative9users have liked this narrative0users have commented on this narrative77users have followed this narrativeRead narrativeMonstarlab Inc. 競合他社Sophia HoldingsLtdSymbol: TSE:6942Market cap: JP¥6.0bSystemSoftSymbol: TSE:7527Market cap: JP¥5.6bO.B.SystemSymbol: TSE:5576Market cap: JP¥6.5bYottaviasLtdSymbol: TSE:5598Market cap: JP¥6.4b価格と性能株価の高値、安値、推移の概要Monstarlab過去の株価現在の株価JP¥104.0052週高値JP¥348.0052週安値JP¥74.00ベータ1.711ヶ月の変化-3.70%3ヶ月変化-36.20%1年変化40.54%3年間の変化-90.57%5年間の変化n/aIPOからの変化-90.33%最新ニュースReported Earnings • Apr 05Full year 2025 earnings released: JP¥5.95 loss per share (vs JP¥285 loss in FY 2024)Full year 2025 results: JP¥5.95 loss per share (improved from JP¥285 loss in FY 2024). Revenue: JP¥7.80b (down 22% from FY 2024). Net loss: JP¥337.0m (loss narrowed 97% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has fallen by 52% per year, which means it is performing significantly worse than earnings.Reported Earnings • Feb 28Full year 2025 earnings released: JP¥5.95 loss per share (vs JP¥285 loss in FY 2024)Full year 2025 results: JP¥5.95 loss per share (improved from JP¥285 loss in FY 2024). Revenue: JP¥7.80b (down 22% from FY 2024). Net loss: JP¥337.0m (loss narrowed 97% from FY 2024).お知らせ • Feb 27Monstarlab Inc., Annual General Meeting, Mar 31, 2026Monstarlab Inc., Annual General Meeting, Mar 31, 2026.分析記事 • Feb 16We Think Monstarlab (TSE:5255) Is Taking Some Risk With Its DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • Jan 09Why We Like The Returns At Monstarlab (TSE:5255)What are the early trends we should look for to identify a stock that could multiply in value over the long term...お知らせ • Dec 27Monstarlab Inc. to Report Fiscal Year 2025 Results on Feb 13, 2026Monstarlab Inc. announced that they will report fiscal year 2025 results on Feb 13, 2026最新情報をもっと見るRecent updatesReported Earnings • Apr 05Full year 2025 earnings released: JP¥5.95 loss per share (vs JP¥285 loss in FY 2024)Full year 2025 results: JP¥5.95 loss per share (improved from JP¥285 loss in FY 2024). Revenue: JP¥7.80b (down 22% from FY 2024). Net loss: JP¥337.0m (loss narrowed 97% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has fallen by 52% per year, which means it is performing significantly worse than earnings.Reported Earnings • Feb 28Full year 2025 earnings released: JP¥5.95 loss per share (vs JP¥285 loss in FY 2024)Full year 2025 results: JP¥5.95 loss per share (improved from JP¥285 loss in FY 2024). Revenue: JP¥7.80b (down 22% from FY 2024). Net loss: JP¥337.0m (loss narrowed 97% from FY 2024).お知らせ • Feb 27Monstarlab Inc., Annual General Meeting, Mar 31, 2026Monstarlab Inc., Annual General Meeting, Mar 31, 2026.分析記事 • Feb 16We Think Monstarlab (TSE:5255) Is Taking Some Risk With Its DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • Jan 09Why We Like The Returns At Monstarlab (TSE:5255)What are the early trends we should look for to identify a stock that could multiply in value over the long term...お知らせ • Dec 27Monstarlab Inc. to Report Fiscal Year 2025 Results on Feb 13, 2026Monstarlab Inc. announced that they will report fiscal year 2025 results on Feb 13, 2026分析記事 • Nov 28There's Reason For Concern Over Monstarlab Inc.'s (TSE:5255) Massive 31% Price JumpThose holding Monstarlab Inc. ( TSE:5255 ) shares would be relieved that the share price has rebounded 31% in the last...Reported Earnings • Nov 18Third quarter 2025 earnings released: EPS: JP¥8.53 (vs JP¥53.64 loss in 3Q 2024)Third quarter 2025 results: EPS: JP¥8.53 (up from JP¥53.64 loss in 3Q 2024). Revenue: JP¥2.05b (down 7.6% from 3Q 2024). Net income: JP¥553.0m (up JP¥2.39b from 3Q 2024). Profit margin: 27% (up from net loss in 3Q 2024).分析記事 • Oct 29Is Monstarlab (TSE:5255) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Reported Earnings • Aug 16Second quarter 2025 earnings released: JP¥2.18 loss per share (vs JP¥162 loss in 2Q 2024)Second quarter 2025 results: JP¥2.18 loss per share (improved from JP¥162 loss in 2Q 2024). Revenue: JP¥1.88b (down 26% from 2Q 2024). Net loss: JP¥115.2m (loss narrowed 98% from 2Q 2024).お知らせ • Jul 02Monstarlab Inc. announced that it has received ¥70.000184 million in fundingOn June 30, 2024. Monstarlab Inc. announced that it has closed the Transaction.お知らせ • Jun 13Monstarlab Inc. announced that it expects to receive ¥70.000184 million in fundingMonstarlab Inc. announced a private placement of 573,772 shares at a price of ¥122 per share for gross proceeds of ¥ 70,000,184 through third party allotment on June 13, 2025.The transaction includes participation from Hiroki Inagawa for 282,787 shares, Eiichi Matsushima for 245,902 shares, Tomoyuki Uno for 28,689 shares, Tatsuro Usui for 16,394 shares. The transaction is approved by board of the directors of the company. The transaction is expected to close on June 30, 2025.Reported Earnings • May 21First quarter 2025 earnings released: JP¥3.09 loss per share (vs JP¥9.91 loss in 1Q 2024)First quarter 2025 results: JP¥3.09 loss per share (improved from JP¥9.91 loss in 1Q 2024). Revenue: JP¥1.90b (down 40% from 1Q 2024). Net loss: JP¥137.0m (loss narrowed 60% from 1Q 2024).Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. Auditor Yuko Miura was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Apr 16+ 1 more updateMonstarlab Inc. to Report Q1, 2025 Results on May 15, 2025Monstarlab Inc. announced that they will report Q1, 2025 results on May 15, 2025Reported Earnings • Apr 05Full year 2024 earnings released: JP¥285 loss per share (vs JP¥70.06 loss in FY 2023)Full year 2024 results: JP¥285 loss per share (further deteriorated from JP¥70.06 loss in FY 2023). Revenue: JP¥10.0b (down 25% from FY 2023). Net loss: JP¥9.95b (loss widened 322% from FY 2023).New Risk • Mar 24New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 34% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.3% average weekly change). Negative equity (-JP¥4.8b). Earnings have declined by 49% per year over the past 5 years. Shareholders have been substantially diluted in the past year (34% increase in shares outstanding). Minor Risk Market cap is less than US$100m (JP¥3.76b market cap, or US$25.1m).New Risk • Feb 23New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 24% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-JP¥4.8b). Earnings have declined by 49% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.0% average weekly change). Shareholders have been diluted in the past year (24% increase in shares outstanding). Market cap is less than US$100m (JP¥3.94b market cap, or US$26.4m).New Risk • Feb 18New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 8.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.0% average weekly change). Negative equity (-JP¥4.8b). Earnings have declined by 49% per year over the past 5 years. Minor Risk Market cap is less than US$100m (JP¥3.29b market cap, or US$21.7m).お知らせ • Feb 17Monstar Lab, Inc., Annual General Meeting, Mar 28, 2025Monstar Lab, Inc., Annual General Meeting, Mar 28, 2025.Reported Earnings • Feb 16Full year 2024 earnings released: JP¥285 loss per share (vs JP¥70.06 loss in FY 2023)Full year 2024 results: JP¥285 loss per share (further deteriorated from JP¥70.06 loss in FY 2023). Revenue: JP¥10.0b (down 25% from FY 2023). Net loss: JP¥9.95b (loss widened 322% from FY 2023).お知らせ • Jan 17+ 1 more updateMonstar Lab, Inc. to Report Q3, 2025 Results on Nov 14, 2025Monstar Lab, Inc. announced that they will report Q3, 2025 results on Nov 14, 2025New Risk • Jan 03New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 9.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-JP¥3.0b). Earnings have declined by 46% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.0% average weekly change). Shareholders have been diluted in the past year (9.4% increase in shares outstanding). Market cap is less than US$100m (JP¥3.30b market cap, or US$21.0m).分析記事 • Dec 05Monstar Lab, Inc. (TSE:5255) Could Be Riskier Than It LooksMonstar Lab, Inc.'s ( TSE:5255 ) price-to-sales (or "P/S") ratio of 0.3x may look like a pretty appealing investment...お知らせ • Sep 20Calvin Rodney Sylvinus Hart agreed to acquire Genieology from Monstar Lab, Inc. (TSE:5255) for approximately ¥240 million.Calvin Rodney Sylvinus Hart agreed to acquire Genieology from Monstar Lab, Inc. (TSE:5255) for approximately ¥240 million on September 19, 2024. A cash consideration of ¥241 million will be paid by the buyer. As part of consideration, ¥241 million is paid towards common equity of Genieology. As of December 31, 2023, Genieology reported total assets of ¥459 million and total common equity of ¥275 million. The expected completion of the transaction is September 30, 2024.Reported Earnings • Aug 19Second quarter 2024 earnings released: JP¥162 loss per share (vs JP¥32.03 loss in 2Q 2023)Second quarter 2024 results: JP¥162 loss per share (further deteriorated from JP¥32.03 loss in 2Q 2023). Revenue: JP¥2.54b (down 24% from 2Q 2023). Net loss: JP¥5.55b (loss widened 406% from 2Q 2023).Reported Earnings • May 18First quarter 2024 earnings released: JP¥9.91 loss per share (vs JP¥6.20 profit in 1Q 2023)First quarter 2024 results: JP¥9.91 loss per share (down from JP¥6.20 profit in 1Q 2023). Revenue: JP¥3.18b (down 13% from 1Q 2023). Net loss: JP¥340.0m (down 273% from profit in 1Q 2023).分析記事 • Apr 11A Piece Of The Puzzle Missing From Monstar Lab, Inc.'s (TSE:5255) 32% Share Price ClimbMonstar Lab, Inc. ( TSE:5255 ) shares have had a really impressive month, gaining 32% after a shaky period beforehand...分析記事 • Feb 26Slammed 34% Monstar Lab, Inc. (TSE:5255) Screens Well Here But There Might Be A CatchMonstar Lab, Inc. ( TSE:5255 ) shares have had a horrible month, losing 34% after a relatively good period beforehand...お知らせ • Feb 16Monstar Lab, Inc., Annual General Meeting, Mar 28, 2024Monstar Lab, Inc., Annual General Meeting, Mar 28, 2024.お知らせ • Dec 06Monstar Lab, Inc. to Report Fiscal Year 2023 Results on Feb 14, 2024Monstar Lab, Inc. announced that they will report fiscal year 2023 results on Feb 14, 2024お知らせ • Dec 05+ 2 more updatesMonstar Lab, Inc. to Report Q2, 2024 Results on Aug 14, 2024Monstar Lab, Inc. announced that they will report Q2, 2024 results on Aug 14, 2024お知らせ • Sep 22Monstar Lab, Inc. (TSE:5255) agreed to acquire ExecutiveSearch.AI K.K.Monstar Lab, Inc. (TSE:5255) agreed to acquire ExecutiveSearch.AI K.K. on September 20, 2023. The consideration for 86 shares to be acquired in October 2023 is ¥413 million. The agreement states that the acquisition is completed in stages: 14 shares will be acquired in 2024, 14 shares in 2025, 14 shares in 2026, and 15 shares in 2027. The acquisition in 2027 completes the transaction, and all the issued shares of common stock will have been acquired. ExecutiveSearch.AI reported net assets of ¥69 million, total assets of ¥103 million, net sales of ¥190 million and operating profit of ¥11 million as at September 30, 2022. The advisory fees for this transaction is ¥12 million. The transaction is expected to close in 2027.New Risk • Aug 17New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: JP¥14.4b (US$98.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risk Market cap is less than US$100m (JP¥14.4b market cap, or US$98.4m).Board Change • Mar 28Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent External Director Chiamin Lai was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.株主還元5255JP ITJP 市場7D6.1%5.0%2.9%1Y40.5%-5.6%39.4%株主還元を見る業界別リターン: 5255過去 1 年間で-5.6 % の収益を上げたJP IT業界を上回りました。リターン対市場: 5255過去 1 年間で39.4 % の収益を上げたJP市場を上回りました。価格変動Is 5255's price volatile compared to industry and market?5255 volatility5255 Average Weekly Movement12.6%IT Industry Average Movement5.2%Market Average Movement4.9%10% most volatile stocks in JP Market9.6%10% least volatile stocks in JP Market2.4%安定した株価: 5255の株価は、 JP市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 5255の weekly volatility ( 13% ) は過去 1 年間安定していますが、依然としてJPの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト2006847Hiroki Inagawamonstar-lab.comMonstarlab Inc.は、子会社とともにアジア太平洋、欧州、中東、アフリカ、米州で情報技術事業を展開している。デジタル・コンサルティング事業」と「その他」の2つのセグメントで事業を展開している。アプリケーションやシステム、ウェブサイト、eコマースプラットフォームの開発、AIやXR機能の統合、APIの開発と統合、顧客データプラットフォームの実装、データウェアハウス、データ統合インフラ、クラウドアプリケーションとインフラの開発、レガシーシステムの近代化、デジタルツインの実装、顧客関係管理の実装などを提供している。また、ユーザーリサーチや戦略立案、アイデア創出、サービスコンセプトやカスタマージャーニーの設計、プロトタイピング、導入支援やパフォーマンス評価、ビジュアル・アイデンティティ、コミュニケーション、ビジュアル・デザイン、ブランド・コンセプト開発、ユーザー・インターフェースや情報アーキテクチャの設計、専門家によるユーザビリティ・レビュー、UXライティング、デザイン・システムの構築なども提供している。また、アイデア創出支援、戦略的ビジネスプランニング、グローバル・ローカル市場機会分析、テクノロジーソーシング、PoC/MVP開発支援、デジタルトランスフォーメーションのプランニングと支援、デジタルインフラの最適化、AI主導のスマートプロセス変革の実施、データ主導の経営推進、新興市場・顧客層の開拓なども行っている。さらに、オフショア開発、アジャイル開発導入、保守・運用アウトソーシング、専門家派遣、人材育成プログラム、技能伝承支援、業務プロセス最適化、ワークフロー自動化ツールの導入などにも取り組んでいる。旧社名はMonstarlab Holdings Inc.で、2025年3月にMonstarlab Inc.に社名変更した。Monstarlab株式会社は2006年に設立され、渋谷に本社を置いている。もっと見るMonstarlab Inc. 基礎のまとめMonstarlab の収益と売上を時価総額と比較するとどうか。5255 基礎統計学時価総額JP¥6.72b収益（TTM）-JP¥423.92m売上高(TTM)JP¥7.80b0.9xP/Sレシオ-15.9xPER（株価収益率5255 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計5255 損益計算書（TTM）収益JP¥7.80b売上原価JP¥4.65b売上総利益JP¥3.15bその他の費用JP¥3.57b収益-JP¥423.92m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-6.56グロス・マージン40.40%純利益率-5.44%有利子負債／自己資本比率905.2%5255 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/09 21:35終値2026/05/08 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Monstarlab Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Shingo KumazawaDaiwa Securities Co. Ltd.
Featured narrative•Software opportunityZenaTechabout 2 months ago author updated this narrativeJOFair Value from Jolt_CommunicationsUS$6.8569.3% 割安 内在価値ディスカウントZenaTech: A big bet on the rise of AI drones and drones-as-a-serviceKey Takeaways ZenaTech is focusing its efforts into building AI drones, combining Drone as a Service, SaaS, and AI as its key revenue drivers. Previously building software for agriculture, ZenaTech has shifted rapidly toward drone services, now driving ~70% of revenue after recent acquisitions.Read full narrative3.2kusers have viewed this narrative9users have liked this narrative0users have commented on this narrative77users have followed this narrativeRead narrative
Reported Earnings • Apr 05Full year 2025 earnings released: JP¥5.95 loss per share (vs JP¥285 loss in FY 2024)Full year 2025 results: JP¥5.95 loss per share (improved from JP¥285 loss in FY 2024). Revenue: JP¥7.80b (down 22% from FY 2024). Net loss: JP¥337.0m (loss narrowed 97% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has fallen by 52% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Feb 28Full year 2025 earnings released: JP¥5.95 loss per share (vs JP¥285 loss in FY 2024)Full year 2025 results: JP¥5.95 loss per share (improved from JP¥285 loss in FY 2024). Revenue: JP¥7.80b (down 22% from FY 2024). Net loss: JP¥337.0m (loss narrowed 97% from FY 2024).
お知らせ • Feb 27Monstarlab Inc., Annual General Meeting, Mar 31, 2026Monstarlab Inc., Annual General Meeting, Mar 31, 2026.
分析記事 • Feb 16We Think Monstarlab (TSE:5255) Is Taking Some Risk With Its DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 • Jan 09Why We Like The Returns At Monstarlab (TSE:5255)What are the early trends we should look for to identify a stock that could multiply in value over the long term...
お知らせ • Dec 27Monstarlab Inc. to Report Fiscal Year 2025 Results on Feb 13, 2026Monstarlab Inc. announced that they will report fiscal year 2025 results on Feb 13, 2026
Reported Earnings • Apr 05Full year 2025 earnings released: JP¥5.95 loss per share (vs JP¥285 loss in FY 2024)Full year 2025 results: JP¥5.95 loss per share (improved from JP¥285 loss in FY 2024). Revenue: JP¥7.80b (down 22% from FY 2024). Net loss: JP¥337.0m (loss narrowed 97% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has fallen by 52% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Feb 28Full year 2025 earnings released: JP¥5.95 loss per share (vs JP¥285 loss in FY 2024)Full year 2025 results: JP¥5.95 loss per share (improved from JP¥285 loss in FY 2024). Revenue: JP¥7.80b (down 22% from FY 2024). Net loss: JP¥337.0m (loss narrowed 97% from FY 2024).
お知らせ • Feb 27Monstarlab Inc., Annual General Meeting, Mar 31, 2026Monstarlab Inc., Annual General Meeting, Mar 31, 2026.
分析記事 • Feb 16We Think Monstarlab (TSE:5255) Is Taking Some Risk With Its DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 • Jan 09Why We Like The Returns At Monstarlab (TSE:5255)What are the early trends we should look for to identify a stock that could multiply in value over the long term...
お知らせ • Dec 27Monstarlab Inc. to Report Fiscal Year 2025 Results on Feb 13, 2026Monstarlab Inc. announced that they will report fiscal year 2025 results on Feb 13, 2026
分析記事 • Nov 28There's Reason For Concern Over Monstarlab Inc.'s (TSE:5255) Massive 31% Price JumpThose holding Monstarlab Inc. ( TSE:5255 ) shares would be relieved that the share price has rebounded 31% in the last...
Reported Earnings • Nov 18Third quarter 2025 earnings released: EPS: JP¥8.53 (vs JP¥53.64 loss in 3Q 2024)Third quarter 2025 results: EPS: JP¥8.53 (up from JP¥53.64 loss in 3Q 2024). Revenue: JP¥2.05b (down 7.6% from 3Q 2024). Net income: JP¥553.0m (up JP¥2.39b from 3Q 2024). Profit margin: 27% (up from net loss in 3Q 2024).
分析記事 • Oct 29Is Monstarlab (TSE:5255) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Reported Earnings • Aug 16Second quarter 2025 earnings released: JP¥2.18 loss per share (vs JP¥162 loss in 2Q 2024)Second quarter 2025 results: JP¥2.18 loss per share (improved from JP¥162 loss in 2Q 2024). Revenue: JP¥1.88b (down 26% from 2Q 2024). Net loss: JP¥115.2m (loss narrowed 98% from 2Q 2024).
お知らせ • Jul 02Monstarlab Inc. announced that it has received ¥70.000184 million in fundingOn June 30, 2024. Monstarlab Inc. announced that it has closed the Transaction.
お知らせ • Jun 13Monstarlab Inc. announced that it expects to receive ¥70.000184 million in fundingMonstarlab Inc. announced a private placement of 573,772 shares at a price of ¥122 per share for gross proceeds of ¥ 70,000,184 through third party allotment on June 13, 2025.The transaction includes participation from Hiroki Inagawa for 282,787 shares, Eiichi Matsushima for 245,902 shares, Tomoyuki Uno for 28,689 shares, Tatsuro Usui for 16,394 shares. The transaction is approved by board of the directors of the company. The transaction is expected to close on June 30, 2025.
Reported Earnings • May 21First quarter 2025 earnings released: JP¥3.09 loss per share (vs JP¥9.91 loss in 1Q 2024)First quarter 2025 results: JP¥3.09 loss per share (improved from JP¥9.91 loss in 1Q 2024). Revenue: JP¥1.90b (down 40% from 1Q 2024). Net loss: JP¥137.0m (loss narrowed 60% from 1Q 2024).
Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. Auditor Yuko Miura was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 16+ 1 more updateMonstarlab Inc. to Report Q1, 2025 Results on May 15, 2025Monstarlab Inc. announced that they will report Q1, 2025 results on May 15, 2025
Reported Earnings • Apr 05Full year 2024 earnings released: JP¥285 loss per share (vs JP¥70.06 loss in FY 2023)Full year 2024 results: JP¥285 loss per share (further deteriorated from JP¥70.06 loss in FY 2023). Revenue: JP¥10.0b (down 25% from FY 2023). Net loss: JP¥9.95b (loss widened 322% from FY 2023).
New Risk • Mar 24New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 34% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.3% average weekly change). Negative equity (-JP¥4.8b). Earnings have declined by 49% per year over the past 5 years. Shareholders have been substantially diluted in the past year (34% increase in shares outstanding). Minor Risk Market cap is less than US$100m (JP¥3.76b market cap, or US$25.1m).
New Risk • Feb 23New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 24% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-JP¥4.8b). Earnings have declined by 49% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.0% average weekly change). Shareholders have been diluted in the past year (24% increase in shares outstanding). Market cap is less than US$100m (JP¥3.94b market cap, or US$26.4m).
New Risk • Feb 18New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 8.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.0% average weekly change). Negative equity (-JP¥4.8b). Earnings have declined by 49% per year over the past 5 years. Minor Risk Market cap is less than US$100m (JP¥3.29b market cap, or US$21.7m).
お知らせ • Feb 17Monstar Lab, Inc., Annual General Meeting, Mar 28, 2025Monstar Lab, Inc., Annual General Meeting, Mar 28, 2025.
Reported Earnings • Feb 16Full year 2024 earnings released: JP¥285 loss per share (vs JP¥70.06 loss in FY 2023)Full year 2024 results: JP¥285 loss per share (further deteriorated from JP¥70.06 loss in FY 2023). Revenue: JP¥10.0b (down 25% from FY 2023). Net loss: JP¥9.95b (loss widened 322% from FY 2023).
お知らせ • Jan 17+ 1 more updateMonstar Lab, Inc. to Report Q3, 2025 Results on Nov 14, 2025Monstar Lab, Inc. announced that they will report Q3, 2025 results on Nov 14, 2025
New Risk • Jan 03New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 9.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-JP¥3.0b). Earnings have declined by 46% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.0% average weekly change). Shareholders have been diluted in the past year (9.4% increase in shares outstanding). Market cap is less than US$100m (JP¥3.30b market cap, or US$21.0m).
分析記事 • Dec 05Monstar Lab, Inc. (TSE:5255) Could Be Riskier Than It LooksMonstar Lab, Inc.'s ( TSE:5255 ) price-to-sales (or "P/S") ratio of 0.3x may look like a pretty appealing investment...
お知らせ • Sep 20Calvin Rodney Sylvinus Hart agreed to acquire Genieology from Monstar Lab, Inc. (TSE:5255) for approximately ¥240 million.Calvin Rodney Sylvinus Hart agreed to acquire Genieology from Monstar Lab, Inc. (TSE:5255) for approximately ¥240 million on September 19, 2024. A cash consideration of ¥241 million will be paid by the buyer. As part of consideration, ¥241 million is paid towards common equity of Genieology. As of December 31, 2023, Genieology reported total assets of ¥459 million and total common equity of ¥275 million. The expected completion of the transaction is September 30, 2024.
Reported Earnings • Aug 19Second quarter 2024 earnings released: JP¥162 loss per share (vs JP¥32.03 loss in 2Q 2023)Second quarter 2024 results: JP¥162 loss per share (further deteriorated from JP¥32.03 loss in 2Q 2023). Revenue: JP¥2.54b (down 24% from 2Q 2023). Net loss: JP¥5.55b (loss widened 406% from 2Q 2023).
Reported Earnings • May 18First quarter 2024 earnings released: JP¥9.91 loss per share (vs JP¥6.20 profit in 1Q 2023)First quarter 2024 results: JP¥9.91 loss per share (down from JP¥6.20 profit in 1Q 2023). Revenue: JP¥3.18b (down 13% from 1Q 2023). Net loss: JP¥340.0m (down 273% from profit in 1Q 2023).
分析記事 • Apr 11A Piece Of The Puzzle Missing From Monstar Lab, Inc.'s (TSE:5255) 32% Share Price ClimbMonstar Lab, Inc. ( TSE:5255 ) shares have had a really impressive month, gaining 32% after a shaky period beforehand...
分析記事 • Feb 26Slammed 34% Monstar Lab, Inc. (TSE:5255) Screens Well Here But There Might Be A CatchMonstar Lab, Inc. ( TSE:5255 ) shares have had a horrible month, losing 34% after a relatively good period beforehand...
お知らせ • Feb 16Monstar Lab, Inc., Annual General Meeting, Mar 28, 2024Monstar Lab, Inc., Annual General Meeting, Mar 28, 2024.
お知らせ • Dec 06Monstar Lab, Inc. to Report Fiscal Year 2023 Results on Feb 14, 2024Monstar Lab, Inc. announced that they will report fiscal year 2023 results on Feb 14, 2024
お知らせ • Dec 05+ 2 more updatesMonstar Lab, Inc. to Report Q2, 2024 Results on Aug 14, 2024Monstar Lab, Inc. announced that they will report Q2, 2024 results on Aug 14, 2024
お知らせ • Sep 22Monstar Lab, Inc. (TSE:5255) agreed to acquire ExecutiveSearch.AI K.K.Monstar Lab, Inc. (TSE:5255) agreed to acquire ExecutiveSearch.AI K.K. on September 20, 2023. The consideration for 86 shares to be acquired in October 2023 is ¥413 million. The agreement states that the acquisition is completed in stages: 14 shares will be acquired in 2024, 14 shares in 2025, 14 shares in 2026, and 15 shares in 2027. The acquisition in 2027 completes the transaction, and all the issued shares of common stock will have been acquired. ExecutiveSearch.AI reported net assets of ¥69 million, total assets of ¥103 million, net sales of ¥190 million and operating profit of ¥11 million as at September 30, 2022. The advisory fees for this transaction is ¥12 million. The transaction is expected to close in 2027.
New Risk • Aug 17New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: JP¥14.4b (US$98.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risk Market cap is less than US$100m (JP¥14.4b market cap, or US$98.4m).
Board Change • Mar 28Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent External Director Chiamin Lai was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
